Abbott to Acquire Nutrition Businesses, Expanding Presence in India
- Details
- Category: Abbott

Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis
- Details
- Category: GlaxoSmithKline

Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
- Details
- Category: Amgen

Q2/2009: Merck Revenues Remain Steady at € 1.9 Billion
- Details
- Category: Merck Group

The US Food and Drug Administration (FDA) has approved Tekturna HCT®
- Details
- Category: Novartis

Genzyme Delivers Solid Second-Quarter Financial Results
- Details
- Category: Genzyme

Pfizer Reports Second-Quarter 2009 Revenues of $11.0 Billion
- Details
- Category: Pfizer

More Pharma News ...
- Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
- Nycomed announces FDA filing for Daxas® in COPD
- Novartis delivers strong operational performance in the first half of 2009
- Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
- Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease
- GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa
- Abbott and GSK to Collaborate on Molecular Diagnostic Test